Research
Hormonal
If GLP-1RAs were made available for all people with obesity and 50% moved into a lower BMI category, there would be a simulated reduction in cumulative cancer cases of 21,443.
Wider access to GLP-1RAs could lead to significant reductions in cancer cases among obese individuals.
StrongSupportsmedium confidence
If GLP-1RAs were made available for all people with obesity and 50 % of people with obesity moved into a lower BMI category, there was a simulated reduction in cumulative cancer cases of 21,443.
Why this rating
Based on the simulation model described in the abstract.
Source
Impact of GLP-1 receptor agonist-induced weight loss on 22 cancers in the next ten years using a Markov state-transition model – A UK weight and wellness cancer landscape analysis
Jiawen Dong et al. · Cancer Epidemiology · 2025
otherCited 3×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →